Novo Nordisk A/S (CPH:NOVO.B)

Novo Nordisk Revenue

Novo Nordisk had revenue of 76.86B DKK in the quarter ending June 30, 2025, with 12.93% growth. This brings the company's revenue in the last twelve months to 311.94B, up 20.90% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

• Revenue (ttm): 311.94B
• Revenue Growth: +20.90%
• P/S Ratio: 5.59
• Revenue / Employee: 3.98M
• Employees: 77,349
• Market Cap: 1,744.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	290.40B	58.14B	25.03%
Dec 31, 2023	232.26B	55.31B	31.26%
Dec 31, 2022	176.95B	36.15B	25.68%
Dec 31, 2021	140.80B	13.85B	10.91%
Dec 31, 2020	126.95B	4.93B	4.04%